Erick Palmer is a partner in Mayer Brown’s Chicago office, where his practice focuses on complex patent litigation and post-grant proceedings before the Patent Trial and Appeal Board.
Erick has provided litigation representation for industry-leading clients in various fields, including chemicals, pharmaceuticals, medical devices, medical diagnostics, nutraceuticals, and food science.
Erick has substantial experience in all aspects of patent cases, from fact discovery, motion practice, and claim construction to expert discovery, dispositive motions, trial, and appeal.
Prior to joining Mayer Brown in 2008, Erick received a Ph.D. in Chemistry from The Ohio State University. He was also a judicial extern for the Honorable Jeffrey S. Sutton of the United States Court of Appeals for the Sixth Circuit.
- Capital University Law School, JD, summa cum laude
- The Ohio State University
- University of Kentucky, BA, summa cum laude
- US Patent and Trademark Office
- US Court of Appeals for the Federal Circuit
Activities : Member, Federal Circuit Bar Association
- Represents global optical fiber coating manufacturer in ten inter partes reviews before the PTO. Obtained final written decisions upholding the patentability of 75% of the 225 claims challenged.
- Represented brand pharmaceutical company in Hatch-Waxman litigation involving a commercially successful antidepressant. On appeal, obtained affirmance of the district court’s finding of no invalidity.
- Represented medical diagnostic company in patent litigation relating to stereotactic surgery. On appeal, obtained affirmance of the district court’s grant of motion to dismiss in favor of Mayer Brown’s client.
- Represented pet food manufacturer in patent litigation related to dog chews. On early motion, obtained dismissal of infringement claims and dismissal with prejudice of the patent owner’s claim for provisional rights.
- Represented brand pharmaceutical company in Hatch-Waxman litigation involving market-leading treatment for rosacea. Defeated early summary judgment motion brought by the generic company and obtained favorable settlement thereafter.
Rate : $$$$